10.1016/S0896-6273(02)01168-6 Neuron 125 PetersA.Kaiserman-AbramofI
Yet, despite the preference for DA production, -cells and -cells still express adrenergic receptors, and for some receptor subtypes, to a significantly greater degree relative to D2R/D3R
As of 2024, roughly 60 FDA-approved peptide medications exist, 140 are in active clinical trials, and more than 500 are in preclinical development.4 Google search volumes for compounds like BPC-157 and MOTS-c hit all-time highs in mid-2024, with more than 50 million tagged video views across YouTube and TikTok.5 The interest is not merely recreational: endurance coaches and practitioners at organizations from the US Olympic Committee to Stanford Athletics are paying close attention, because the intersection of peptide science, AI-driven drug discovery, and wearable-data analytics is producing insights that could reshape how we train, recover, and extend competitive careers
Triple agonists [12] such as GLP-1RA, GIP-RA plus glucagon-RA are in development and may show comparable efficacy in weight loss to tirzepatide by targeting multiple pathways involved in energy regulation [13]
For instance, acyl-CoA synthetase long-chain family member 4 (ACSL4), prostaglandin-endoperoxide synthase 2 (PTGS2), and transferrin receptor (TFRC) are highly expressed in psoriatic skin lesions, while GPX4, ferritin light chain (FTL), and ferritin heavy chain 1 (FTH1) expression is lower compared to healthy skin lesions
